Evidence map›Paper›PMID 32291379›Full record

ArticleAging2020

PP2A subunit PPP2R2C is downregulated in the brains of Alzheimer's transgenic mice.

Waiian Leong, Wei Xu, Bo Wang, Shuaiyun Gao, Xiuyun Zhai, Cuicui Wang, Eric Gilson, Jing Ye, Yiming Lu

Open access · greenAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Targeting PP2A in cancer: an underrated option.Journal of experimental & clinical cancer research : CR · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Tau Toxicity in Neurodegeneration.Molecular neurobiology · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Waiian LeongShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Affiliated to Shanghai Jiaotong University School of Medicine, International Laboratory in Hematology, Aging and Cancer, State Key Laboratory of Medical Genomics, Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Shanghai, P.R. China.
Wei XuShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Affiliated to Shanghai Jiaotong University School of Medicine, International Laboratory in Hematology, Aging and Cancer, State Key Laboratory of Medical Genomics, Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Shanghai, P.R. China.
Bo WangShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Affiliated to Shanghai Jiaotong University School of Medicine, International Laboratory in Hematology, Aging and Cancer, State Key Laboratory of Medical Genomics, Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Shanghai, P.R. China.
Shuaiyun GaoShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Affiliated to Shanghai Jiaotong University School of Medicine, International Laboratory in Hematology, Aging and Cancer, State Key Laboratory of Medical Genomics, Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Shanghai, P.R. China.
Xiuyun ZhaiShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Affiliated to Shanghai Jiaotong University School of Medicine, International Laboratory in Hematology, Aging and Cancer, State Key Laboratory of Medical Genomics, Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Shanghai, P.R. China.
Cuicui WangShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Affiliated to Shanghai Jiaotong University School of Medicine, International Laboratory in Hematology, Aging and Cancer, State Key Laboratory of Medical Genomics, Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Shanghai, P.R. China.
Eric GilsonShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Affiliated to Shanghai Jiaotong University School of Medicine, International Laboratory in Hematology, Aging and Cancer, State Key Laboratory of Medical Genomics, Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Shanghai, P.R. China.
Jing YeShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Affiliated to Shanghai Jiaotong University School of Medicine, International Laboratory in Hematology, Aging and Cancer, State Key Laboratory of Medical Genomics, Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Shanghai, P.R. China.
Yiming LuShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Affiliated to Shanghai Jiaotong University School of Medicine, International Laboratory in Hematology, Aging and Cancer, State Key Laboratory of Medical Genomics, Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Shanghai, P.R. China.
Ruijin Hospital · CNState Key Laboratory of Medical GenomicsCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeting of PP2A suggests a close link to tau-related cognitive and functional declines. However, little is known about how the expression of PP2A subunits and PP2A activity are dysregulated in the course of AD, precluding any specific targeting strategy for restoring PP2A in AD patients. Although the PP2A heterotrimer containing the regulatory subunit PR55/Bα (encoded by the

Indexed as

AgingAlzheimer DiseaseAnimalsBrainCells, CulturedDown-RegulationFemaleHEK293 CellsHumansMaleMiceMice, TransgenicProtein Phosphatase 2Protein Processing, Post-TranslationalRNA, Messengertau ProteinsMapt protein, mouseProtein Phosphatase 2RNA, Messengertau ProteinsAlzheimer’s diseasePP2A phosphatasePPP2R2Ctau phosphorylation

Identifiers

PMID32291379
PMCPMC7202491
OpenAlexW3016088298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.